Amy Rose
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Dermatology top 5%
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 14
- Cutaneous Melanoma Detection and Management 7
- CAR-T cell therapy research 5
-
- Melanoma and MAPK Pathways 3
- Co-authors
- Iman Osman (13 shared papers)Eva Hernando (6 shared papers)David J. Goldberg (2 shared papers)Jan Zakrzewski (4 shared papers)Douglas Hanniford (3 shared papers)Miguel F. Segura (3 shared papers)Ilana Belitskaya‐Lévy (2 shared papers)David Polsky (4 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer (2 papers)Journal of Translational Medicine (2 papers)Cancer Research (2 papers)Dermatologic Surgery (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Amy Rose
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 487
- Dermatology 116
- Oncology 322
- Molecular Biology 701
- Immunology 148
Countries citing papers authored by Amy Rose
This map shows the geographic impact of Amy Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Rose more than expected).
Fields of papers citing papers by Amy Rose
This network shows the impact of papers produced by Amy Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Rose. The network helps show where Amy Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 475 | |
| 2 | 2010 | 186 | |
| 3 | 2013 | 93 | |
| 4 | 2010 | 88 | |
| 5 | 2018 | 64 | |
| 6 | 2011 | 57 | |
| 7 | 2010 | 49 | |
| 8 | 2011 | 46 | |
| 9 | 2013 | 45 | |
| 10 | 2010 | 44 | |
| 11 | 2009 | 43 | |
| 12 | 2012 | 22 | |
| 13 | 2020 | 18 | |
| 14 | 2005 | 17 | |
| 15 | 2010 | 16 | |
| 16 | 2011 | 14 | |
| 17 | 2011 | 14 | |
| 18 | 2013 | 14 | |
| 19 | MDM2 expression and regulation in prostate cancer racial disparity. | 2009 | 12 |
| 20 | 2005 | 10 |
About Amy Rose
Amy Rose is a scholar working on Oncology, Molecular Biology, Cancer Research, Epidemiology and Rheumatology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (7 papers), Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (5 papers), Urinary Bladder and Prostate Research (4 papers), Cancer Genomics and Diagnostics (4 papers), Urinary Tract Infections Management (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Cancer Research (487 citations), Dermatology (116 citations), Oncology (322 citations), Molecular Biology (701 citations) and Immunology (148 citations). Amy Rose has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Iman Osman, Eva Hernando, David J. Goldberg, Jan Zakrzewski, Douglas Hanniford, Miguel F. Segura, Ilana Belitskaya‐Lévy, David Polsky, Richard L. Shapiro and Farbod Darvishian. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Translational Medicine, Cancer Research and Dermatologic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.